tiprankstipranks
Trending News
More News >
Niagen Bioscience, Inc. (NAGE)
:NAGE
US Market
Advertisement

Niagen Bioscience (NAGE) Ratios

Compare
570 Followers

Niagen Bioscience Ratios

NAGE's free cash flow for Q2 2025 was $0.65. For the 2025 fiscal year, NAGE's free cash flow was decreased by $ and operating cash flow was $0.10. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.88 2.40 2.61 2.78 1.96
Quick Ratio
3.24 1.70 1.78 2.00 1.25
Cash Ratio
2.70 1.32 1.13 1.59 1.00
Solvency Ratio
0.70 -0.12 -0.49 -0.92 -0.77
Operating Cash Flow Ratio
0.95 0.35 -0.84 -1.37 -0.64
Short-Term Operating Cash Flow Coverage
22.03 0.00 -21.69 -44.09 -17.10
Net Current Asset Value
$ 59.35M$ 23.03M$ 21.18M$ 22.79M$ 10.29M
Leverage Ratios
Debt-to-Assets Ratio
0.04 0.06 0.08 0.08 0.04
Debt-to-Equity Ratio
0.05 0.12 0.15 0.15 0.10
Debt-to-Capital Ratio
0.05 0.10 0.13 0.13 0.09
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.43 1.93 1.89 1.82 2.34
Debt Service Coverage Ratio
18.19 0.00 -20.96 -39.60 -24.46
Interest Coverage Ratio
0.00 0.00 -6.21K -492.24 -279.63
Debt to Market Cap
<0.01 0.00 <0.01 <0.01 <0.01
Interest Debt Per Share
0.04 0.05 0.06 0.07 0.03
Net Debt to EBITDA
-3.15 6.14 0.95 0.92 0.81
Profitability Margins
Gross Profit Margin
63.62%60.76%59.40%61.51%59.53%
EBIT Margin
14.33%-6.70%-25.85%-40.14%-33.50%
EBITDA Margin
15.58%-4.66%-23.24%-37.73%-30.95%
Operating Profit Margin
14.33%-6.70%-25.85%-40.14%-33.50%
Pretax Profit Margin
15.76%-5.91%-22.96%-40.22%-33.62%
Net Profit Margin
15.24%-5.91%-20.05%-37.89%-31.19%
Continuous Operations Profit Margin
15.24%-5.91%-22.96%-40.22%-33.62%
Net Income Per EBT
96.72%100.00%87.36%94.21%92.76%
EBT Per EBIT
109.96%88.19%88.79%100.20%100.36%
Return on Assets (ROA)
19.37%-8.98%-26.73%-44.19%-48.19%
Return on Equity (ROE)
35.46%-17.35%-50.39%-80.55%-112.54%
Return on Capital Employed (ROCE)
24.09%-16.30%-51.48%-67.30%-90.73%
Return on Invested Capital (ROIC)
22.67%-15.98%-43.30%-61.72%-79.65%
Return on Tangible Assets
19.43%-9.07%-27.07%-44.85%-49.58%
Earnings Yield
2.26%-4.90%-12.33%-10.17%-6.31%
Efficiency Ratios
Receivables Turnover
12.04 15.97 8.49 12.91 22.00
Payables Turnover
3.09 3.20 3.02 2.49 2.54
Inventory Turnover
2.94 2.26 1.99 1.91 2.05
Fixed Asset Turnover
27.98 18.42 11.40 9.17 13.37
Asset Turnover
1.27 1.52 1.33 1.17 1.54
Working Capital Turnover Ratio
1.94 2.90 2.40 2.87 3.47
Cash Conversion Cycle
36.57 70.65 105.33 72.97 50.65
Days of Sales Outstanding
30.30 22.86 42.97 28.28 16.59
Days of Inventory Outstanding
124.28 161.68 183.13 191.24 177.80
Days of Payables Outstanding
118.02 113.90 120.77 146.55 143.74
Operating Cycle
154.58 184.54 226.10 219.52 194.40
Cash Flow Ratios
Operating Cash Flow Per Share
0.27 0.10 -0.22 -0.36 -0.17
Free Cash Flow Per Share
0.26 0.10 -0.22 -0.37 -0.18
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
0.99 0.98 1.02 1.02 1.01
Dividend Paid and CapEx Coverage Ratio
76.57 48.09 -45.20 -59.08 -74.65
Capital Expenditure Coverage Ratio
76.57 48.09 -45.20 -59.08 -74.65
Operating Cash Flow Coverage Ratio
6.44 2.17 -3.55 -5.14 -6.48
Operating Cash Flow to Sales Ratio
0.18 0.09 -0.21 -0.36 -0.18
Free Cash Flow Yield
2.66%6.91%-13.17%-9.78%-3.66%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
44.16 -20.43 -8.11 -9.83 -15.86
Price-to-Sales (P/S) Ratio
6.78 1.21 1.63 3.73 4.95
Price-to-Book (P/B) Ratio
12.20 3.54 4.09 7.92 17.85
Price-to-Free Cash Flow (P/FCF) Ratio
37.64 14.48 -7.59 -10.23 -27.29
Price-to-Operating Cash Flow Ratio
36.91 14.17 -7.76 -10.40 -27.65
Price-to-Earnings Growth (PEG) Ratio
1.99 0.29 0.18 -0.37 0.35
Price-to-Fair Value
12.20 3.54 4.09 7.92 17.85
Enterprise Value Multiple
40.34 -19.77 -6.04 -8.96 -15.17
Enterprise Value
730.93M 76.98M 101.16M 227.95M 278.26M
EV to EBITDA
40.34 -19.77 -6.04 -8.96 -15.17
EV to Sales
6.28 0.92 1.40 3.38 4.70
EV to Free Cash Flow
34.92 11.05 -6.56 -9.28 -25.90
EV to Operating Cash Flow
34.46 10.82 -6.70 -9.43 -26.25
Tangible Book Value Per Share
0.81 0.40 0.40 0.46 0.25
Shareholders’ Equity Per Share
0.81 0.40 0.41 0.47 0.27
Tax and Other Ratios
Effective Tax Rate
0.03 0.00 0.13 0.06 0.07
Revenue Per Share
1.47 1.18 1.03 1.00 0.97
Net Income Per Share
0.22 -0.07 -0.21 -0.38 -0.30
Tax Burden
0.97 1.00 0.87 0.94 0.93
Interest Burden
1.10 0.88 0.89 1.00 1.00
Research & Development to Revenue
0.05 0.06 0.07 0.06 0.06
SG&A to Revenue
0.17 0.30 0.39 0.54 0.51
Stock-Based Compensation to Revenue
0.03 0.06 0.08 0.09 0.12
Income Quality
1.20 -1.44 0.91 0.89 0.53
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis